Skip to main content

Table 3 Clinical and sociodemographic characteristics at treatment initiation for participants assigned to the outcome death and not assigned to death among those lost to follow-up (n = 1132)

From: Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada

Characteristic

Total (n)

Not assigned death (%)

Assigned death (%)

P-value

Participants lost to follow-up

1132

792 (70.0)

340 (30.0)

 

Sex

   

0.787

Female

232

164 (70.7)

68 (29.3)

 

Male

900

628 (69.8)

272 (30.2)

 

History of IDUa

   

<0.001

Yes

177

53 (29.9)

124 (70.1)

 

No

651

538 (82.6)

113 (17.4)

 

Aboriginal ancestryb

   

<0.001

Yes

30

13 (43.3)

17 (56.7)

 

No

487

379 (77.8)

108 (22.2)

 

CD4 cell count (cells/μL)

   

<0.001

<350

912

604 (66.2)

308 (33.8)

 

≥350

220

188 (85.5)

32 (14.5)

 
  1. IDU injection drug use
  2. an = 828
  3. bn = 517